Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (1): 31-35.doi: 10.3969/j.issn.1000-6621.2021.01.007
• Original Articles • Previous Articles Next Articles
ZENG Jian-feng, YANG Min, TANG Fang, ZHU Hui-min, CHEN Tao, DENG Guo-fang, ZHANG Pei-ze()
Received:
2020-12-07
Online:
2021-01-10
Published:
2021-01-12
Contact:
ZHANG Pei-ze
E-mail:peizezhang@aliyun.com
ZENG Jian-feng, YANG Min, TANG Fang, ZHU Hui-min, CHEN Tao, DENG Guo-fang, ZHANG Pei-ze. Clinical characteristics of pulmonary tuberculosis in hospitalized patients with diabetes mellitus[J]. Chinese Journal of Antituberculosis, 2021, 43(1): 31-35. doi: 10.3969/j.issn.1000-6621.2021.01.007
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.01.007
项目类别 | 活动性肺结核组 (31例) | 非活动性肺结核组 (32例) | 未发现异常 (2585例) | 合计 (2648例) | |||
---|---|---|---|---|---|---|---|
性别 | |||||||
男 | 28(90.32) | 27(84.38) | 1663(64.33) | 1718(64.88) | |||
女 | 3(9.68) | 5(15.62) | 922(35.67) | 930(35.12) | |||
年龄组(岁) | |||||||
15~ | 1(3.23) | 0(0.00) | 24(0.93) | 25(0.94) | |||
26~ | 3(9.68) | 0(0.00) | 177(6.85) | 180(6.80) | |||
36~ | 8(25.81) | 3(9.37) | 464(17.95) | 475(17.94) | |||
46~ | 5(16.13) | 10(31.25) | 739(28.59) | 754(28.47) | |||
56~ | 9(29.03) | 5(15.63) | 644(24.91) | 658(24.85) | |||
66~ | 4(12.90) | 8(25.00) | 364(14.08) | 376(14.20) | |||
76~ | 1(3.23) | 6(18.75) | 150(5.80) | 157(5.93) | |||
86~95 | 0(0.00) | 0(0.00) | 23(0.89) | 23(0.87) | |||
并发其他疾病 | |||||||
高血压 | 6(19.35) | 20(62.50) | 1231(47.62) | 1257(47.47) | |||
冠心病 | 4(12.90) | 8(25.00) | 386(14.93) | 398(15.03) | |||
慢性乙型病毒性肝炎 | 6(19.35) | 3(9.38) | 215(8.32) | 224(8.46) | |||
肝硬化 | 0(0.00) | 0(0.00) | 40(1.55) | 40(1.51) | |||
终末期肾病 | 1(3.23) | 0(0.00) | 11(0.43) | 12(0.45) | |||
恶性肿瘤 | 0(0.00) | 6(18.75) | 233(9.01) | 239(9.03) | |||
风湿性疾病 | 0(0.00) | 1(3.13) | 72(2.79) | 73(2.76) | |||
器官移植 | 0(0.00) | 0(0.00) | 5(0.19) | 5(0.19) |
临床资料 | 活动性肺结核组 (31例) | 非活动性肺结核组 (32例) | 统计检验值 | P值 |
---|---|---|---|---|
性别[例数(构成比,%)] | χ2=-0.502 | 0.478 | ||
男 | 28(90.32) | 27(84.38) | ||
女 | 3(9.68) | 5(15.62) | ||
平均年龄(岁, | 51.16±13.06 | 61.78±12.88 | t=-3.236 | 0.002 |
糖化血红蛋白(HbA1c)(%, | 9.18±2.85 | 8.05±1.69 | t=1.884 | 0.070 |
血白蛋白(g/L, | 39.18±5.32 | 39.66±4.34 | t=-0.408 | 0.685 |
并发其他疾病[例数(比率,%)] | χ2=11.535 | 0.420 | ||
高血压 | 6(19.35) | 20(62.50) | ||
冠心病 | 4(12.90) | 8(25.00) | ||
慢性乙型病毒性肝炎 | 6(19.35) | 3(9.38) | ||
终末期肾病 | 1(3.23) | 0(0.00) | ||
恶性肿瘤 | 0(0.00) | 6(18.75) | ||
风湿性疾病 | 0(0.00) | 1(3.13) | ||
糖尿病治疗情况[例数(构成比,%)] | χ2=1.520 | 0.823 | ||
首发,未开始治疗 | 6(19.35) | 8(25.00) | ||
无治疗 | 4(12.90) | 2(6.25) | ||
口服药品治疗 | 10(32.27) | 8(25.00) | ||
胰岛素注射治疗 | 4(12.90) | 5(15.63) | ||
联合治疗 | 7(22.58) | 9(28.12) |
[1] | World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. |
[2] |
Misra A, Gopalan H, Jayawardena R, et al. Diabetes in develo-ping countries. J Diabetes. 2019,11(7):522-539. doi: 10.1111/1753-0407.12913.
doi: 10.1111/1753-0407.12913 URL pmid: 30864190 |
[3] | Lin Y, Harries AD, Kumar AMV, et al. Management of diabetes mellitus-tuberculosis: a guide to the essential practice. Paris: International Union Against Tuberculosis and Lung Disease, World Diabetes Foundation, 2019. |
[4] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09. |
[5] | 陈红光, 刘民, 顾芳慧. 中国大陆地区肺结核合并糖尿病患病率的Meta分析. 中华流行病学杂志, 2013,34(11):1128-1133. doi: 10.3760/cma.j.issn.0254-6450.2013.011.019. |
[6] | 《中国糖尿病防治指南》编写组. 中国糖尿病防治指南, 北京: 北京大学医学出版社, 2004: 11-12. |
[7] | 国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 《中国防痨杂志》编辑委员会. 肺结核活动性判断规范及临床应用专家共识. 中国防痨杂志, 2020,42(4):301-307. doi: 10.3969/j.issn.1000-6621.2020.04.001. |
[8] |
Cheng J, Zhang H, Zhao YL, et al. Mutual Impact of Diabetes Mellitus and Tuberculosis in China. Biomed Environ Sci, 2017,30(5):384-389. doi: 10.3967/bes2017.051.
doi: 10.3967/bes2017.051 URL pmid: 28549496 |
[9] |
Jeon CY, Harries AD, Baker MA, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health, 2010,15(11):1300-1314. doi: 10.1111/j.1365-3156.2010.02632.x.
doi: 10.1111/j.1365-3156.2010.02632.x URL pmid: 20958887 |
[10] |
Martinez N, Kornfeld H. Tuberculosis and diabetes: from bench to bedside and back. Int J Tuberc Lung Dis, 2019,23(6):669-677. doi: 10.5588/ijtld.18.0805.
doi: 10.5588/ijtld.18.0805 URL pmid: 31315698 |
[11] |
Lin Y, Li L, Mi F, et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health, 2012,17(10):1302-1308. doi: 10.1111/j.1365-3156.2012.03069.x.
doi: 10.1111/j.1365-3156.2012.03069.x URL |
[12] | 汪娟, 许缃, 姜静, 等. 2013—2017年上海市徐汇区糖尿病并发肺结核患者特征登记转归分析. 结核病与肺部健康杂志, 2019,8(1):29-32. doi: 10.3969/j.issn.2095-3755.2019.01.008. |
[13] | 汪娟, 许缃, 蔡晓峰, 等. 对糖尿病患者进行肺结核筛查的效果与成本效益分析. 中国防痨杂志, 2019,41(9):968-973. doi: 10.3969/j.issn.1000-6621.2019.09.011. |
[14] |
Ji Y, Cao H, Liu Q, et al. Screening for pulmonary tuberculosis in high-risk groups of diabetic patients. Int J Infect Dis, 2020,93:84-89. doi: 10.1016/j.ijid.2020.01.019.
doi: 10.1016/j.ijid.2020.01.019 URL pmid: 31978585 |
[15] |
Paton NI, Borand L, Benedicto J, et al. Diagnosis and mana-gement of latent tuberculosis infection in Asia: Review of current status and challenges. Int J Infect Dis, 2019,87:21-29. doi: 10.1016/j.ijid.2019.07.004.
doi: 10.1016/j.ijid.2019.07.004 URL pmid: 31301458 |
[16] |
Hayashi S, Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Trop Med Int Health, 2018,23(10):1058-1070. doi: 10.1111/tmi.13133.
doi: 10.1111/tmi.13133 URL pmid: 30062731 |
[17] |
Jackson C, Southern J, Lalvani A, et al. Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort. Thorax, 2019,74(1):91-94. doi: 10.1136/thoraxjnl-2017-211124.
doi: 10.1136/thoraxjnl-2017-211124 URL pmid: 29764958 |
[18] | Lee MR, Huang YP, Kuo YT, et al. Diabetes Mellitus and Latent Tuberculosis Infection: A Systematic Review and Metaanalysis. Clin Infect Dis, 2017,64(6):719-727. doi: 10.1093/cid/ciw836.Erratum in: Clin Infect Dis,2017,65(2):356. |
[19] |
Oglesby W, Kara AM, Granados H, et al. Metformin in tuberculosis: beyond control of hyperglycemia. Infection, 2019,47(5):697-702. doi: 10.1007/s15010-019-01322-5.
doi: 10.1007/s15010-019-01322-5 URL pmid: 31119504 |
[1] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[2] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[3] | Li Leilei, Shi Lei, Wang Lin, Li Hongwei, Xu Liran, Pang Yu, Song Yanzheng. Clinical characteristics analysis of HIV-infected cases diagnosed with tuberculosis after surgery due to pulmonary nodules [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 266-273. |
[4] | Qiu Yong, Quan Zhuo, Qu Rong, Tian Fajun, Li Meng, Wang Gengsheng, Wang Ya, Guo Mingcheng, Gao Qian. Evaluation of different tuberculosis diagnostic tools for detecting patients in a primary-level clinic in rural China: a real-world retrospective study [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 181-188. |
[5] | Zhang Guoqin, Qu Ting, Meng Qinglin, Zhou Lin, Liu Eryong. Implementation update of strategy for the control of tuberculosis and HIV/AIDS co-infection in China [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 12-17. |
[6] | Huang Tao, Jian Huiyong, Wang Xinqi, Liu Nianqiang, Yipar Aihaiti, Wang Mingzhe, Jiayinati Jingesi, Wang Senlu. Analysis of influencing factors of treatment outcomes in patients with pulmonary tuberculosis complicated with diabetes mellitus in Xinjiang Uygur Autonomous Region [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1083-1088. |
[7] | Yang Liangzi, Zhang Peize, Lu Shuihua. Interpretation of World Health Organization’s Co-administration of Treatment for Drug-resistant Tuberculosis and Hepatitis C: 2024 Update [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 874-876. |
[8] | Liu Ling, Zeng Yi, Wang Jin, Liu Xiaoling, Liu Yan, Lin Feishen, Guo Jing. Construction and evaluation of a model for predicting malnutrition in patients with pulmonary tuberculosis and diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 903-909. |
[9] | Cai Qinghe, Fu Hui, Chen Ruiming, Fan Youming, Yang Qingwei. Analysis of the clinical characteristics and influencing factors of pulmonary tuberculosis patients with diabetes mellitus in Shantou City from 2016 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 926-934. |
[10] | Jiang Bijia, Chen Cheng, Zhou Jinyi, Zhu Limei, Su Jian, Lu Wei. Analysis of tuberculosis incidence and influencing factors in type 2 diabetic patients in community [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 951-957. |
[11] | Chai Dongyu, Qin Shuyi, Zhang Ronghua, Zou Nannan, Wang Xin. Analysis of risk factors for viral pneumonia combined with invasive pulmonary mycosis [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 750-755. |
[12] | Fu Keyan, Zhu Bangzheng, Ye Jian. Research progress on interstitial lung disease combined with Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 823-829. |
[13] | Liu Guizhen, Deng Guofang. Interpretation of Evidence and research gaps identified during development of policy guidelines for tuberculosis (Second edition): tuberculosis related comorbidity [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 618-624. |
[14] | Li Yao, Fang Zhe, Luo Danlin, Hu Yanmei, Tang Mi, Tang Zhigang, Wen Xinmin, Zhang Yong, Yao Bibo, Wang Qi, Yi Hengzhong. Clinical characteristics and prognosis of patients with novel coronavirus infection complicated with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 687-698. |
[15] | Yang Rui, Li Ling, Chen Jinou, Xu Lin. Analysis of influencing factors of anti-tuberculosis treatment effect for pulmonary tuberculosis patients complicated with diabetes in Yunnan Province from 2017 to 2021 [J]. Chinese Journal of Antituberculosis, 2024, 46(5): 519-524. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||